This inventor holds 1 USPTO granted patent. Top assignee: Targacept, Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Erin E. Reich: Innovator in Pharmaceutical Compositions
Introduction
Erin E. Reich is a notable inventor based in Nashville, TN (US). She has made significant contributions to the field of pharmaceuticals, particularly in developing compositions and methods for treating central nervous system disorders. Her innovative work has the potential to impact many patients suffering from various conditions.
Latest Patents
Erin E. Reich holds 1 patent for her invention titled "Pharmaceutical compositions and methods for use." This patent focuses on treating patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders. The treatment involves administering aryloxyalkylamines and arylthioalkylamines, including compounds like (2-(5-bromo(3-pyridylthio))-ethyl)methylamine and (3-(5-bromo(3-pyridylthio))-propyl)methylamine, among others.
Career Highlights
Erin is currently associated with Targacept, Inc., where she continues to advance her research and development efforts. Her work at Targacept has positioned her as a key player in the pharmaceutical industry, focusing on innovative solutions for complex medical issues.
Collaborations
Throughout her career, Erin has collaborated with esteemed colleagues, including Michael B. Consilvio and Gary Maurice Dull. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Erin E. Reich's contributions to pharmaceutical innovations demonstrate her commitment to improving patient care through scientific advancements. Her work continues to inspire and pave the way for future developments in the field.